SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Acquired by Transcend Capital Advisors LLC

Transcend Capital Advisors LLC boosted its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 52.5% in the fourth quarter, Holdings Channel.com reports. The firm owned 48,204 shares of the exchange traded fund’s stock after acquiring an additional 16,605 shares during the period. Transcend Capital Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $4,304,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the company. Phoenix Holdings Ltd. grew its holdings in SPDR S&P Biotech ETF by 0.8% during the 3rd quarter. Phoenix Holdings Ltd. now owns 2,151,359 shares of the exchange traded fund’s stock valued at $157,092,000 after purchasing an additional 17,221 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in SPDR S&P Biotech ETF by 103.3% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,771,000 shares of the exchange traded fund’s stock valued at $129,318,000 after purchasing an additional 900,000 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. acquired a new stake in SPDR S&P Biotech ETF during the 3rd quarter valued at $102,900,000. Bank Julius Baer & Co. Ltd Zurich boosted its stake in SPDR S&P Biotech ETF by 4.4% during the 3rd quarter. Bank Julius Baer & Co. Ltd Zurich now owns 627,917 shares of the exchange traded fund’s stock valued at $45,850,000 after acquiring an additional 26,728 shares during the last quarter. Finally, MBB Public Markets I LLC boosted its stake in SPDR S&P Biotech ETF by 67.0% during the 3rd quarter. MBB Public Markets I LLC now owns 514,411 shares of the exchange traded fund’s stock valued at $37,562,000 after acquiring an additional 206,337 shares during the last quarter.

SPDR S&P Biotech ETF Trading Up 1.5 %

NYSEARCA XBI traded up $1.27 during trading hours on Friday, reaching $83.49. 10,452,779 shares of the company traded hands, compared to its average volume of 11,723,970. SPDR S&P Biotech ETF has a 12 month low of $63.80 and a 12 month high of $103.52. The stock has a market capitalization of $6.49 billion, a PE ratio of 11.47 and a beta of 1.08. The company has a 50 day moving average of $92.69 and a two-hundred day moving average of $84.64.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.